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Abstract 
Background 
Mental health policy in many countries is oriented around recovery. The evidence base 
for service-level pro-recovery interventions is lacking. 
Methods 
Two-site cluster randomised controlled trial in England (ISRCTN02507940). REFOCUS 
is a one-year team-level intervention targeting staff behaviour (increasing focus on 
patient values, preferences, strengths, goal-striving) and staff-patient relationships 
(coaching, partnership). 27 community-based adult mental health teams were randomly 
allocated to treatment-as-usual (n=13) or treatment-as-usual plus REFOCUS (n=14). 
Baseline (n=403) and one-year follow-up (n=297) outcomes were assessed for randomly 
selected patients with psychosis, representing 88% of target recruitment. Primary 
outcome was recovery, assessed using Questionnaire about Processes of Recovery 
(QPR). 
Findings 
Intention-to-treat analysis using multiple imputation found no difference in QPR Total 
(control 40·0 (s.d.10·2), intervention 40·6 (s.d.10·1), adjusted difference 0·68, 95%CI: -
1·7 to 3·1, p=·58), or sub-scales. Secondary outcomes which improved in the 
intervention group were functioning (adjusted difference 6·96, 95%CI 2·8 to 9·2, p<·001) 
and staff-rated unmet need (adjusted difference 0·80, 95%CI 0·2 to 1·4, p=·01). This 
pattern remained after covariate adjustment and completer analysis (n=275). Higher-
participating teams had higher staff-rated pro-recovery behaviour change (adjusted 
difference -0·4, 95%CI -0·7 to -0·2, p=·001) and patients had higher QPR Interpersonal 
scores (adjusted difference -1·6, 95%CI -2·7 to -0·5, p=·005) at follow-up. Intervention-
group patients incurred £1,062 (95%CI -£1,103 to £3,017) lower adjusted costs. 
Interpretation 
Supporting recovery may, from the staff perspective, improve functioning and reduce 
needs. Overcoming implementation barriers may increase staff pro-recovery behaviours 
and interpersonal aspects of patient-rated recovery. 
Funding 
National Institute for Health Research. 
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Introduction 
An orientation towards supporting personal recovery is national mental health policy in 
England and Wales1 and throughout much of the English-speaking world. This focus on 
recovery has been re-iterated in the most recent Chief Medical Officer’s report on public 
mental health.2 In this context, personal recovery is defined as a way of living a 
satisfying, hopeful, and contributing life even with any limitations caused by illness.3 This 
modern meaning of recovery can be contrasted with the traditional focus of clinical 
recovery on symptomatology and disability. Epidemiological evidence indicates that the 
majority of people experiencing mental illness will over the long term experience clinical 
recovery.4 
 
Scientific knowledge about interventions to support personal recovery is emerging, 
including for example Cochrane reviews about vocational rehabilitation, peer support, 
and advance directives.5 Programmes are underway internationally to support pro-
recovery system transformation6. Despite this progress, policy is markedly in advance of 
research and practice. In addition to introducing new and evidence-based interventions, 
it is becoming clear that supporting personal recovery will also involve change in staff-
patient relationships, treatments (e.g. with emerging evidence that psychosocial 
interventions for psychosis may be effective in the absence of pharmacotherapy),7 and 
outcomes (with more diverse outcomes such as employment and relationships in 
addition to symptomatology and functioning).8 Initiatives to support a recovery orientation 
are needed at higher levels within the system than the clinician-patient level, in order to 
achieve this organisational culture change within mental health systems. 
 
In this report we describe an evaluation of the REFOCUS Intervention: a manualised 
team-level intervention to support personal recovery.9 The evidence base for the 
intervention is summarised in the Research in Context Panel, and the understanding of 
practice change was informed by the theory of planned behaviour.10 This theory 
proposes behavioural intent is influenced by attitudes and subjective norms, and by the 
perceived level of behavioural control. Meta-analysis of health research suggest the 
theory accounts for over 20% of actual behaviour.11 The REFOCUS Intervention is 
intended to be trans-diagnostic and suitable for all types of adult community mental 
health teams. An international review found that staff can support recovery through what 
they do with patients (the Supporting Recovery practice domain), and how they work 
with patients (the Working Relationship practice domain).12 The intervention therefore 
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targets care content (the ‘what’) by supporting the use of three working practices, and 
care processes (the ‘how’) through training staff in coaching and giving opportunities for 
other recovery-promoting relationships. The intervention and evaluation are based on 
the REFOCUS Model (contained in the manual),9 which following the MRC Framework 
for Complex Health Interventions13 specifies the intended causal pathway from 
intervention, through changes in practice and patient experience, to patient outcome of 
enhanced recovery. We report a multi-site cluster randomised controlled trial comparing 
outcomes for patients in community mental health teams receiving or not receiving the 
REFOCUS Intervention. Although the intervention is trans-diagnostic, our evaluation 
focussed on the impact on patients with psychosis, with the aim of providing evidence to 
inform disorder-specific clinical guidelines. We hypothesised that recovery would be 
improved for patients with psychosis, in comparison with usual care. 
 
Methods 
Study design and participants 
We undertook a cluster randomised controlled trial across two mental health Trusts in 
England. The trial manual9 and protocol (available at www.biomedcentral.com/1471-
244X/11/185)14 were published, ethical approval was obtained (East London Research 
Ethics Committee, 11/LO/0083), the trial was registered (ISRCTN02507940, controlled-
trials.com), researchers were trained in administration of all standardised measures, and 
trial conduct was overseen by a Trial Steering Committee. 
 
As the intervention is at the level of the team, we used a cluster design with a cluster 
being a community mental health team, to reduce contamination, because teams are the 
unit of service delivery in the NHS. Team inclusion criteria were adult, community-based 
mental health teams providing care co-ordination using the Care Programme 
Approach,15 a national framework for care co-ordination and resource allocation in 
mental health care. Two sites were used: South London and Maudsley NHS Foundation 
Trust (SLaM) in south-east London and 2gether NHS Foundation Trust in 
Gloucestershire. SLaM is the largest mental health trust in the UK, has an annual 
income of £330m, spent across over 100 sites spanning urban and suburban settings. It 
employs 4,500 staff in 296 teams, works with 34,128 service users. 2gether is a rural / 
semi-rural Trust, employing 806 staff in 23 adult mental health teams, and working with 
4,301 service users. In both sites, all potentially eligible teams were identified by service 
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managers, and then researchers discussed participation with the service and team 
managers and lead clinicians. 
 
Patient participants were identified from each team’s caseload. Inclusion criteria were 
aged 18-65 years, primary clinical diagnosis of psychosis, e.g. schizophrenia, schizo-
affective disorder, bipolar disorder, no immediate plans for discharge or transfer, not 
currently receiving in-patient care or in prison, speaks and understands English, not 
participating in substantial other study, is sufficiently well to participate in opinion of 
clinician, and is in regular contact (as judged by the team) with at least one worker in the 
team. Exclusion criteria were being unable to give consent or being unknown to, or 
uncontactable by, the service. The caseload was screened for initial eligibility (age, 
diagnosis) based on clinical records, clinicians obtained assent from the patient to be 
approached by researchers, and then written informed consent and baseline data were 
obtained from participants by researchers before randomisation. 
 
Staff inclusion criteria were providing clinical input to a participating team, not also 
providing clinical input to another participating team, and (for staff suggested as the key 
informant by the patient) being in regular clinical contact with the participating service 
user. All staff gave written informed consent and completed baseline assessments 
before randomisation. 
 
Randomisation and masking 
Teams were allocated on an equal basis to intervention (treatment as usual plus 
REFOCUS Intervention) or control (treatment as usual), stratified by wave (four SLaM 
Boroughs, two 2gether localities) to ensure balance. Block randomisation of teams was 
undertaken by the independent Mental Health and Neuroscience Clinical Trials Unit 
(MH&NCTU). For each team, the screened caseload of potentially eligible patient 
participants was randomly ordered using procedures set out by MH&NCTU, and 
participants were then recruited in list order. Participating staff, patients and researchers 
were aware of allocation status at follow-up. 
 
Procedures 
All teams were multidisciplinary and provided care co-ordination under the Care 
Programme Approach (CPA), whose key features include systematic arrangements for 
assessing health and social needs, formation of a care plan identifying the health and 
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social care required from a variety of providers, appointment of a key worker to monitor 
and co-ordinate care, and regular review of the care plan. 
 
Teams allocated to the intervention arm additionally received the REFOCUS 
Intervention. The REFOCUS intervention is described in detail in a published manual,9 
but in brief comprises a one-year, whole-team intervention to increase community 
mental health team support for recovery. It aims to impact upon team and individual staff 
values (which can be conflicting)16, recovery-related knowledge, skills and behaviour, 
and staff-patient relationships. The intervention has two components: behavioural and 
interpersonal. The behavioural component comprises three desired behaviours by staff, 
called Working Practices (WPs). WP1 is Understanding Values and Treatment 
Preferences, and involves focussing on the patient’s values and identity beyond being a 
patient, and placing their preferences at the centre of care planning. WP2 is Assessing 
Strengths, and involves using a standardised assessment of personal and social 
strengths to identify existing and potential resources the patient can build on. WP3 is 
Supporting Goal-striving, and involves orienting clinical care around goals valued by the 
patient. These working practices are undertaken in the context of the interpersonal 
component, called Recovery-promoting Relationships, which included training staff to 
use coaching skills in interactions with patients,17 and undertaking a Partnership Project, 
in which staff and patients from the same team take on a joint and non-clinical task, co-
produced between staff and patients, with a small amount of resources (£500 per team). 
Approaches to supporting implementation were: intervention briefing meetings 
separately for staff and patients / informal carers about the study; 12 hours (three four-
hour sessions) of staff training in personal recovery provided by two trainers (one with a 
professional background and one with a service use background); 16 hours (one eight-
hour day, two four-hour sessions, telephone support, optional booster coaching 
sessions) of training in coaching for recovery from a coaching trainer; six externally 
facilitated team manager reflection groups to support culture change; six team reflection 
groups (three externally facilitated, three unfacilitated) to foster experiential learning; and 
use of a reflective practice tool in individual supervision. 
 
Outcomes 
The primary outcome was recovery, assessed using the Questionnaire about the 
Process of Recovery (QPR).18 This measure was identified as most appropriate in a 
systematic review of recovery measures.19 QPR is a 22-item patient-rated assessment 
7 
 
of recovery, developed from a qualitative study led by service user-researchers.20. 
Example of items are ‘I can actively engage with life’ and ‘I am able to develop positive 
relationships with other people’. Each item is rated on a five-point scale from 0 (Disagree 
Strongly) to 4 (Agree strongly). The initial version comprised two sub-scales: QPR 
Intrapersonal (17 items, range 0-68) and QPR Interpersonal (5 items, range 0-20), with 
higher scores indicating increased recovery. Adequate internal consistency 
(Intrapersonal 0·94, Interpersonal 0·77), construct validity, and test-retest reliability 
(Intrapersonal 0·87, Interpersonal 0·76) were demonstrated. A subsequent evaluation by 
the measure developers using a new dataset found a 15-item (range 0-60) one factor 
solution, with items all coming from the QPR Intrapersonal sub-scale and demonstrating 
adequate internal consistency (0·93) and test-retest reliability (0·70).21 Their evaluation 
found a significant correlation between the 15-item QPR and standardised measures of 
symptomatology, hope and self-esteem. Three scores are produced based on means 
ratings: QPR Intrapersonal subscale (17 items), QPR Interpersonal subscale (5 items), 
and the extrapolated QPR Total score (15 items), all with range 0 (low recovery) to 4 
(high recovery). 
 
Scoring and references for remaining measures are given in Appendix Table 1. 
Secondary patient-rated outcome measures were hope (Herth Hope Index [HHI]), quality 
of life (Manchester Short Assessment of Quality of Life [MANSA]), empowerment 
(Mental Health Confidence Scale [MHCS]), well-being (Warwick-Edinburgh Mental Well-
Being Scale [WEMWBS]), and met and unmet needs (Camberwell Assessment of 
Needs Short Appraisal Schedule-Patient [CANSAS-P]). Secondary patient-rated 
experience measures were satisfaction (Client Satisfaction Questionnaire [CSQ]) and 
recovery support (INSPIRE). Secondary staff-rated outcomes were met and unmet 
needs (CANSAS-Staff [CANSAS-S]), functioning (Global Assessment of Functioning 
[GAF]), and social disability (Health of the Nation Outcome Scale [HoNOS]). 
Researchers rated symptomatology (Brief Psychiatric Rating Scale [BPRS]) and service 
use in the previous six months (Client Service Receipt Inventory [CSRI]). 
 
For the quantitative element of the process evaluation, staff completed measures of their 
recovery-related knowledge and attitudes (Recovery Knowledge Inventory [RKI]), 
attitudes towards mental illness (Mental Illness: Clinicians’ Attitudes [MICA]), and two 
unstandardised measures. The Participation Scale [PS] rated participation (i.e. 
attendance and engagement) in the key intervention components of personal recovery 
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training, coaching training, and team reflection sessions. The Recovery Practice Scale 
[RPS] assessed self-rated skills, behavioural intent, and behaviour in relation to 
coaching, values, strengths, goal-striving, and partnership relationships.  
 
Data collection was undertaken by researchers who were trained in all measures. 
Baseline data were collected prior to the allocation date. Teams were contacted four 
months before allocation, and most data were collected in the month before the 
allocation date. All staff were asked to complete RKI, MICA, and RPS. Researchers met 
with patients, who after giving informed consent completed all patient-rated measures 
(QPR [primary outcome], CANSAS-P, HHI, MANSA, MHCS, WEMWBS, CSQ, INSPIRE) 
and identified a paired member of staff from their team (either their care co-ordinator or 
other appropriate professional). Researchers completed BPRS and CSRI with the 
patient. The identified paired staff were then approached and asked to complete 
CANSAS-S, HoNOS, and GAF. Teams were then allocated to either intervention or 
control. One year after randomisation, all assessments were repeated, with intervention 
group staff also completing PS. Follow-up patient data were sought irrespective of any 
change in circumstances (e.g. team disbanded, discharged, move to new Trust, in 
prison, currently in-patient). Data collection began one year after allocation date, with 
most data collected by one month later. Patient participants were offered £10 for their 
time after both assessments, and entered into a £50 prize draw. Staff data were 
collected from the same member of staff where possible, otherwise from an appropriate 
alternate. 
 
Paper data were transcribed to an electronic database. Researchers were trained in 
data entry and followed a data entry protocol to ensure consistency. Data validation 
rules were used in the database to reduce transcription errors. All ID numbers were then 
checked to ensure match between paper and electronic data, and all missing data were 
manually checked to ensure correct entry. A random 20% sample of service user-rated 
(QPR, CSQ and CANSAS-P) and staff-rated (CANSAS-S, GAF, HoNOS, MICA, RKI, 
RPS) follow-up data were manually checked against paper copies, with agreement of 
99.75% (staff) and 99.66% (service users). 
 
Statistical analysis 
The primary outcome was QPR. Our target analysable sample published in the protocol 
was 336 patients, using a sample size calculation assuming 29 teams with 17% attrition 
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to 25 teams, an estimated team-level Intra Cluster Correlation of 0·05 (a conservative 
estimate of the similarities of teams),22 15 patients per team with 7% attrition to 14 per 
team, and parameter estimates of medium standardised effect size (0·4), alpha=0·05 
and power 0·8. Analysis was done by FP and PM (who were masked to treatment 
allocation), using Stata 11. The proportion of missing data across primary and secondary 
outcomes is shown in Appendix Table 4. Missing data were estimated for the whole 
sample (other than the six participants who had died by follow-up) using multiple 
imputation by chained equation (‘MICE’ command) with 50 imputations. The imputation 
model reflected clustering at team level, and (as multiple imputation relies on the 
assumption that data are missing at random (MAR)) included the baseline outcome 
measures as well as covariates in the imputation model to increase the likelihood of the 
MAR assumption and improve the estimation of the missing values. Sensitivity analyses 
showed that the distributions of the imputed items and complete cases were 
comparable, produced equivalent result patterns (shown in Appendix Table 6), and 
analysis based on missing data imputed for outcome measures at baseline and follow-
up (compared with baseline only) was not associated with increased biased estimates as 
indicated by Monte Carlo estimates.23 
 
Our main analysis was conducted using intention-to-treat (ITT) principles (irrespective of 
whether they received the intervention or not) on the imputed data. Regression analysis 
was used to assess study arm differences on primary and secondary outcomes while 
adjusting for baseline scores.24 We took team-level clustering into account by using 
random effects regression analyses with maximum likelihood estimation using the 
‘xtmixed’ command. The model was also adjusted for wave, to reflect the stratification 
design. We used prospective alpha allocation to correct for Type I error inflation due to 
multiple testing.25 We set the experiment-wise alpha (αe) at 0·10, with the significance 
level for testing the primary outcome set to 0·05 (αp) while the remaining 0·05 of alpha 
can be distributed equally among secondary outcomes (i.e. α=0·05/14=0·004). Scores 
screening was implemented prior to our analyses whilst model diagnostics were 
conducted following our regression analyses. 
 
Sensitivity analyses were then conducted, involving adjustment for sociodemographic 
covariates which may be associated with our outcomes.26 These covariates, collected at 
baseline and chosen due to association with primary and secondary outcomes, were 
gender, age, years using mental health services, ethnicity (white British vs. other), 
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accommodation type (privately owned and rented vs. other), marital status (single vs. 
relationship), and education (higher education vs. not). Covariates were entered 
simultaneously into the regression model to assess whether results were modified. 
 
Finally, we conducted post-hoc analyses relating to participation. To assess whether 
staff participation at team level was associated with QPR follow-up scores, adjusted for 
baseline, we extrapolated a measure of team participation by pooling the ratings on PS 
for each team (α = ·89), using data only from staff who did not move teams and had both 
baseline and follow-up ratings. We used a median split to dichotomise intervention 
teams into High or Low participation, allowing a variable ‘Team Participation’ (Control, 
Low participation, High participation) to be extrapolated.  
 
We were also interested in assessing the association between staff participation and 
follow-up staff process measures for non-moving staff with complete data. We used a 
median split on PS across all teams, to identify low and high participating staff within the 
intervention group, allowing extrapolation of a ‘Staff Participation’ variable (Control, Low 
participation, High participation).  
 
We regressed patient outcome (missing data estimated following scale guidelines or pro-
rated where less than 20% of items were missing) on Team Participation, and staff 
process measures (for non-moving staff with complete data) on Staff Participation, whilst 
taking into account clustering at the team level using the Stata ‘xtmixed’ command, 
adjusting the model for baseline scores and Trust centre. 
 
The cost of the intervention was based on the staff time involved in delivering it 
combined with unit costs for those staff members (derived from unit costs27 and NHS 
Reference Costs, and shown in Appendix Table 7). These costs were then divided by 
the current caseload numbers for each team to derive cost per service user. This is a 
conservative approach because it assumes that the training will only benefit current 
service users. If we instead assume that future services users may also benefit then the 
cost would be reduced. Other service use data included contacts with primary and 
secondary health care services (including days in hospital) and social care. No 
imputation was used for loss to follow-up, but we used the standard economic evaluation 
approach that when a service was used but number of contacts not recorded, imputation 
using median values from complete cases was used. This occurred for a small number 
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of cases and a wide range of services, and was required to allow total costs to be 
calculated. Costs were calculated by combining the service use data with appropriate 
unit cost information (NHS Reference costs 2012/13). Costs were compared between 
the two groups for participants with baseline and follow-up cost data, using a 
bootstrapped regression model to account for the likely skewed data and with baseline 
costs controlled for. Costs are reported in 2012/13 UK pounds. 
 
Role of the funding source 
The funder had no role in study design, data collection, data analysis, data 
interpretation, the writing of this report, or the decision to submit for publication. 
 
 
Results 
Between April 2011 and May 2012, 27 teams (18 SLaM, 9 2gether) and 403 patients 
were recruited (Figure 1). 
 
Insert Figure 1 here 
 
Teams comprised 14 (9 SLaM, 5 2gether) in the intervention arm and 13 (9 SLaM, 4 
2gether) in the control arm (Appendix Table 2). Teams comprised 13 Recovery Teams 
providing long-term support to patients with complex health and social needs (4 control, 
9 intervention), four Psychosis Teams specialising in work with complex need patients 
with psychosis (2 control, 2 intervention), three High Support Forensic Teams for 
patients with complex needs and risk issues (1 control, 2 intervention), three Assertive 
Outreach Teams for hard-to-engage patients (3 control), two Supported Living Teams for 
patients in supported accommodation (2 control), one Low Support Team for patients 
with less complex needs (1 intervention), and one Early Intervention Team for patients in 
the first 3-5 years of psychosis (1 control). 
 
Baseline characteristics of patients are shown in Table 1. 
 
Insert Table 1 here 
 
Patients in the intervention group were more likely to live in privately owned/rented 
accommodation (chi2(1)=8·92, p=·003), to be in a relationship (chi2(1)=5·6, p=·02) and to 
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be unemployed (chi2(1)=5·7, p =·003), although these differences are not significant 
after Bonferroni adjustment (adjusted p-value<0·001) to account for multiple testing. The 
control group had more social disability rated on HoNOS (t(364)=4·0, p<0·001), but did 
not differ significantly on any other primary or secondary outcome (p-values ranging from 
·02 to ·91) or total costs or process evaluation measure. Overall we conclude that 
allocation was unbiased. 
 
Implementation 
A total of 28 intervention briefing sessions were run by researchers for patients / carers 
(14 teams) and staff (14 teams). Attendance ranged from 0 to 25 patients, and 50% to 
80% staff per team attended. 41 of the planned 42 recovery training sessions were run, 
with 8 to 24 attenders (median 14.4) in session 1, 4 to 21 (median 13.1) in session 2 and 
6 to 15 (median 10.4) in session 3. All 42 of the planned 42 coaching training sessions 
were run, with 12 to 21 attenders (median 14.7) in session 1, 7 to 19 (median 12.0) in 
session to and 5 to 24 (median 11.3) in session 3. The proportion of staff attending these 
training sessions cannot easily be quantified because (as discussed in the next section) 
the high staff turn-over rate complicates the denominator. However, the research team’s 
impression was that the majority of staff attended. 
 
12 of the intended 36 externally facilitated team reflection groups were run, with 
attendance ranging from 5 to 21 (median 10.0). No formal records were kept of the 
unfacilitated team reflection groups or the team manager reflection groups due to 
research team capacity limitations, but the research team’s impression was that these 
did not in general happen. Reasons for reduced engagement were low team motivation 
and logistical challenges (e.g. difficulties in obtaining cover for whole-team sessions, 
staff being too busy). There was no evidence of the Supervision Reflection Form being 
used in supervision sessions. Partnership Projects were events or activities planned and 
run jointly by staff and patients, with a budget of £500. Overall, five of the intended 14 
Partnership Projects were run, comprising building a web-site, Christmas party, and an 
information session for a service user group (SLaM), and Olympics sports day and 
three-day outward bound course (2Gether). 
 
Towards the end of their time in the trial, two teams (one intervention, one control) 
disbanded but it was still possible to obtain follow-up data from patients and paired staff 
(but not unpaired staff). 
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Outcome 
A total of 532 staff participated in baseline and follow-up. Of these, 336 were in the same 
team at baseline and follow-up, 105 left after baseline, 70 joined before follow-up, and 
21 moved between teams (9 to a team in the same arm, 8 from intervention to control, 
and 4 from control to intervention). Six patient participants (3 intervention, 3 control) died 
during the study period, each for reasons identified by their clinician as un-related to the 
intervention, and were disregarded for analysis. No harms due to the intervention were 
reported.  
 
At one-year follow-up, QPR (primary outcome) data were collected for 275 (69%) of the 
397 participants (Appendix Table 3). Missingness across QPR scales was not 
associated with any sociodemographic covariate and only CANSAS-P Met needs among 
the clinical measure (t(388)=2·2, p=·02). Patients with complete information on QPR at 
follow-up had higher met needs scores at baseline than those with missing data, 
although the difference became non-significant after adjusting for multiple pairwise 
comparisons. Rates for secondary outcome data collection ranged from 60% for MANSA 
to 91% for GAF. Missing data are characterised in Appendix Table 4. 
 
In relation to complete cases (n=255, 121 control, 134 intervention), QPR mean scores 
were stable between baseline and follow-up in both study arms for QPR Total (control 
mean(s.d.): baseline 38·6(9·5) vs. follow-up 40·2(10·3); intervention: 38·5(9·8) vs. 
40·6(10·1)), QPR Intrapersonal (control: 43·6(10·6) vs. 45·5(10·3); intervention: 
43·7(10·6) vs. 46·1(11·1)) and QPR Interpersonal (control: 13·1(2·8) vs. 13·4(2·7); 
intervention: 13·6(2·2) vs. 13·8(2·6)). 
 
Intention-to-treat analysis 
ITT analysis for all 397 participants from all 27 teams (average cluster size 15, range 13 
to 17) indicated that intervention group patients did not differ on QPR Total (b=·63, 
p=·55, 95%CI: -1.41 to 2.67), QPR Intrapersonal (b=·49, p=·44, 95%CI: 1·71 to 2·70) or 
QPR Interpersonal (b=·13, p=·75, 95%CI: -·93 to ·67) subscales at follow-up. The only 
differences in secondary outcomes were improved scores on the staff-rated GAF and 
CANSAS-S Unmet Need measures (with the CANSAS-S effect being non-significant 
after alpha adjustment for multiple comparison) in the intervention group at follow-up 
(Table 2).  
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Insert Table 2 here 
 
After adjusting for covariates, effect sizes were weakened for CANSAS-S Unmet needs 
(b=-0·68, p=·07, 95%CI -1·42 to -0·006) and GAF (b=5·32, p=·002, 95%CI 2·03 to 8·61) 
(Appendix Table 5). Patterns were not modified across the other scales. ITT analysis on 
complete cases is shown in Appendix Table 6, and produced an equivalent pattern of 
results to the ITT analysis with imputed data. 
 
As indicated by the Intra Cluster Correlations in Table 2, there was an effect of team on 
QPR Interpersonal, HHI, MANSA, MHCS, BPRS, GAF and all CANSAS measures. 
Examination of residuals revealed some skewness on the CSQ scale but the results 
were confirmed using bootstrap standard errors (data not shown).  
 
As part of our post hoc analysis, we explored the association between Team 
Participation and follow-up QPR (average cluster size 11, range 7 to 14). We found QPR 
Interpersonal scores adjusted for baseline varied across Team Participation 
(chi2(2)=8·23, p=·016). Patients in high participation teams had significantly higher QPR 
Interpersonal scores at follow-up than patients in low participation intervention teams 
and control teams (Table 3). Intra Cluster Correlation coefficient was 0.0 for all QPR 
scales. 
 
Insert Table 3 here 
 
Table 3 also shows that high participation teams also had more improvements on two 
secondary outcomes – HoNOS (becoming non-significant after Bonferroni adjustment) 
and GAF. No other effect on secondary outcomes was found. 
 
To understand why recovery-supporting relationships may have improved in teams 
whose staff participated more in the intervention, our process evaluation investigated 
staff changes in recovery knowledge (RKI; average cluster size 10, range 4 to 18), 
attitudes towards mental illness (MICA; average cluster size 10, range 5 to 17) and self-
rated fidelity (average cluster size 9, range 4 to 16) (Table 4). Intra Cluster Correlation 
was 0·0 for all measures. 
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Insert Table 4 here 
 
Participation level by staff was not associated with adjusted follow-up scores on MICA 
and RKI. High staff participation was however associated with self-rated pro-recovery 
behaviour (chi2(2)=10·92, p=·004). Specifically, intervention team staff with higher 
participation reported significantly higher scores for pro-recovery behaviours than low-
participating staff. 
 
Service use information was analysed for a subsample of 266 patients due to data 
availability. Service use in the six months prior to baseline and in the six months prior to 
one-year follow-up showed a high level of contact with GPs and care coordinators (Table 
5). The intensity of the use of some services at baseline and follow-up showed large 
variation, for example number of contacts with occupational therapists rose from 8 to 50 
in the intervention arm, but this was for a small number of participants. Around two-thirds 
had contacts with psychiatrists at baseline, but this fell slightly to 55% for the intervention 
group by follow-up. Around one-quarter of participants in both groups had contacts with 
support workers during each period. At baseline around a half had day care contacts, 
falling to 38% for both groups by follow-up. 
 
Insert Table 5 here 
 
The mean intervention cost was £120 (Appendix Table 8), but this varied from £22 to 
£357. The most expensive service was psychiatric inpatient care even though this was 
used by relatively few participants (6% control group, 4% intervention group). Total 
service use costs were lower for intervention group participants at both baseline (£2,997 
vs. £3,754) and follow-up (£2,752 vs. £3,853). Adjusting for baseline, the cost difference 
between intervention and control groups was £1,062 (95% CI, -£1,103 to £3,017), i.e. 
receiving the intervention was associated with lower costs, but the difference was not 
statistically significant. Patients in the high participation intervention teams had services 
costs that were on average £657 less than patients in low participation intervention 
teams, but again this was not statistically significant (95% CI, -£1,555 to £4,783). As 
there was no significant difference in either cost or primary outcome, further cost-
effectiveness analysis was not undertaken. 
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Discussion 
In this two-site cluster randomised controlled trial we evaluated a team-level intervention 
in 27 community adult mental health teams. There was no effect on the primary outcome 
of recovery. Most secondary outcomes did not differ, with the exceptions of 
improvements in the intervention group for functioning (which remained after adjusting 
for multiple testing) and staff-rated unmet need (which was not significant after 
adjusting). Although there was no evidence of changes in staff knowledge, skills or 
attitudes, self-reported pro-recovery behaviours did increase in staff with high 
participation (compared to those with low participation). Consistent with this, patients in 
high-implementing teams had higher scores on QPR Interpersonal sub-scale than 
patients in low-implementing teams. Finally, the intervention was associated with lower 
costs, but the difference was not statistically significant. 
 
Why was no improvement shown in the primary outcome of recovery? Four explanations 
can be considered. First, and the explanation we favour, is that the intervention was 
inadequately implemented. Staff participation (i.e. both physical presence and full 
engagement in training) was self-rated by (unavoidably unblinded) staff who may 
therefore have been susceptible to social desirability bias, i.e. rating fuller engagement 
than was actually experienced. The bias may be modest, because there is no obvious 
reason why it would not have an equivalent impact across all intervention arm staff, thus 
introducing an inflation rather than a bias. Also, the outcome measure was patient-rated. 
Noting this possibility of bias, however, the study showed that where staff participated 
more, there was an increase in self-reported pro-recovery behaviours and patient-
reported recovery in the relationships sub-scale of the QPR. A qualitative process 
evaluation nested in the trial investigated the experiences of staff,28 and found evidence 
that implementation barriers occurred at the individual, team and organisation level. A 
recent Cochrane review has shown that implementation of treatment guidelines within 
specialist mental health services is often poor.29 Implementation of evidence-based 
interventions in routine practice face three 'translational roadblocks': adoption in 
principle, early implementation and persistence of implementation.30 Although policy 
supports the implementation of pro-recovery intervention (adoption in principle), this may 
not lead to early implementation. Broader implementation strategies are needed, 
including leadership and organisational culture.31 
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Second, the REFOCUS Intervention may be ineffective in its primary aim of improving 
personal recovery within the one-year time frame of the intervention. Indeed, the original 
REFOCUS Intervention was 18 months, and needed to be shortened due to trial 
recruitment issues. Participants had been using mental health services for an average of 
more than 15 years, suggesting settled staff-patient relationships. Other studies have 
showed that trusting relationships with staff can take longer to form than possible in a 
time-limited intervention.32 Future research might evaluate the REFOCUS intervention 
with an inception cohort of new referrals to the team, to test the impact on staff-patient 
relationships which are less established. Similarly, comparison between different groups 
of workers (e.g. multidisciplinary versus unidisciplinary teams, teams with versus without 
peer support workers) would allow contamination at the level of staff and any interaction 
between worker profession and implementation to be investigated. 
 
Third, existing practice of control group staff may have already been pro-recovery. 
Control group staff received no formal training through REFOCUS, and although the 
intervention manual was available to download, we found no evidence of difference in 
primary outcome in either arm, and little evidence of contamination due to staff 
movement. For example, many staff in SLaM teams in both arms would previously have 
received some recovery training,33 so sustained changes in control group cannot be 
excluded. However, the recovery orientation of participating teams as measured by RKI 
(control mean 2·94, intervention mean 2·97) was lower than the mean RKI score of 3·94 
found in an Australian study,34 suggesting there was not a high recovery orientation at 
baseline. 
 
Finally, although the choice of endpoint assessment was based on recommendations 
from a systematic review,19 the QPR has not previously been used as a primary 
outcome in a trial and its sensitivity to change has not been fully established, raising the 
possibility of an insufficiently responsive measure failing to detect change. One 
perspective which has been advanced is that evaluation of the process of recovery using 
the outcome-oriented methods of evidence-based medicine is intrinsically problematic, 
and more sociological approaches are needed.35 In an unpublished qualitative 
evaluation of the experience of patient participants in the trial, effective implementation 
was associated with positive changes in process (more open and collaborative 
relationships with staff), hope and empowerment, highlighting the challenges of 
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capturing the impact of complex interventions. As a minimum, further psychometric 
evaluation of QPR and other candidate recovery measures is indicated. 
 
In relation to the protocol,14 this report addresses Objective 1 (intervention 
effectiveness). Other objectives are addressed elsewhere: Objective 2 (Validation of the 
REFOCUS Model) in published36 and submitted process evaluation papers; Objective 3 
(Optimise trial parameters) through this trial report and a revised intervention manual;37 
and Objective 4 (the relationship between clinical and recovery outcomes) in a submitted 
paper. The main protocol deviation was that efforts to estimate researcher blinding at 
follow-up were abandoned, when it became clear that being blind to team (i.e. allocation 
status) was logistically not possible for the researchers. 
 
We identify several strengths. The intervention is theory-based, and the mixed-methods 
evaluation in routine clinical settings across two sites included a range of quantitative 
and qualitative approaches to understanding fidelity, intermediate processes, and 
outcome. The clinical population is representative, although the inclusion criterion of 
clinical judgement about being well enough (to allow consideration of the full range of 
reasons why being approached to participate may not be appropriate) and the relatively 
good social functioning indicated by GAF and HoNOS scores indicate that the most 
disabled people on the caseload may not have participated. The full range of adult 
mental health teams typically provided in NHS Trusts was included, which maximises 
representativeness. One limitation is the absence of a pilot study to inform 
implementation, which might have identified in advance the practice change challenges 
found in this trial: high staff turnover within teams with low morale as a consequence of 
significant reorganisation taking place across both Trusts. Applying a structured 
assessment of feasibility,36 indicates that the intervention involves several 
implementation barriers, including staff training, complexity, human resources and staff 
time. We identified organisational leadership and stability plus readiness to change at 
team level as predictors of implementation,28 which could provide criteria for inclusion of 
high-implementing teams in future evaluations. A second limitation is the recruitment 
shortfall. The analysable sample comprised 297 against a target of 336, primarily due to 
a higher-than-anticipated 26% (106/403) patient attrition rate at follow-up. Achievement 
of an 88% target may mean the study was under-powered to detect difference. Third, the 
design did not stratify by team type, raising the possibility of differential implementation 
across different team types. The relationship between team type and outcome was not 
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analysed in this study because of the uneven allocation and because categories were 
derived from team name and may therefore be overlapping, but future trials might more 
formally establish team type and either use a homogenous sample or stratify by team 
type. 
 
The study contributes to a wider context (Panel), and has a number of clinical 
implications. From the staff perspective, efforts to support recovery may lead to 
improved functioning and may also reduce unmet need for people with psychosis 
(though not from the patient perspective). It is plausible that conversations between staff 
and patients about values, treatment preferences, and strengths will translate over time 
into changes in functioning and assessed need. In this study the observed differences 
do not seem to have been mediated through changes in the recovery variables studied, 
indicating a complex relationship between these variables. If the positive impact in high-
participating teams is not due to staff bias in rating implementation, then the REFOCUS 
Intervention has the potential to be an effective pro-recovery intervention, if 
implementation barriers can be addressed. At the societal level, anti-stigma campaigns 
have been found to make attainment of valued social roles more possible.38 Within 
mental health services, the challenge may be to embed as an organisational culture an 
expectation of partnership-based staff-patient relationships and a focus on the values 
and treatment preferences, strengths and goals of patients. Fully supporting recovery 
may therefore require interventions across the whole mental health service, including the 
patient as an active partner and involving a combination of evidence-based patient-level 
interventions,5 team-level interventions such as REFOCUS, and organisational 
transformation approaches.39 
 
Insert Panel here 
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 Control Intervention 
SOCIODEMOGRAPHICS n (%) n (%) 
Gender Male 127 (66%) 131 (63%) 
Female 66 (34%) 78 (37%) 
Ethnicity White  95 (49%) 115 (56%) 
Non-white 98 (51%) 92 (44%) 
Accommodation Owned/rented 22 (12%) 48 (23%) 
Supported 168 (88%) 161 (73%) 
Relationship Single 158 (82%) 151 (72%) 
In a relationship 35 (18%) 59 (28%) 
Education Secondary  95 (50%) 111 (54%) 
Higher education 96 (50%) 96 (46%) 
 mean (s.d.) mean (s.d.) 
Age (years) 42·99 (11.56) 44·87 (10.22) 
Use of mental health services (years) 15.52 (10.89) 16·13 (11·49) 
PATIENT-RATED OUTCOME MEASURES 
QPR (n=365) Total 38·97 (9·10) 38·53 (9·31) 
   Intrapersonal 43·95 (10·10) 43·77 (10·18) 
  Interpersonal 12·94 (2·67) 13·55 (2·43) 
CANSAS-P Met (n=390) 3·66 (2·82) 3·98 (3·33) 
CANSAS-P Unmet (n=390) 3·58 (2·79) 3·54 (3·01) 
HHI (n=362) 35·92 (4·94) 35·25 (4·81) 
MANSA (n=275) 4·60 (0·88) 4·75 (0·97) 
MHCS (n=335) 66·38 (14·63) 65·23 (14·40) 
WEMWBS (n=373) 46·68 (10·36) 47·39 (9·51) 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ (n=380) 25·51 (5·08) 25·24 (5·25) 
INSPIRE Relationship (n=377) 76·76 (14·95) 77·77 (17·55) 
INSPIRE Support (n=396) 59·39 (20·68) 65·41 (21·48) 
STAFF-RATED OUTCOME MEASURES 
BPRS (n=349) 31·90 (9·17) 33·63 (10·13) 
CANSAS-S met (n=387) 5·74 (3·52) 5·80 (3·67) 
CANSAS-S unmet (n=387) 3·50 (2·79) 3·19 (2·82) 
GAF (n=379) 64·15 (14·84) 64·66 (13·88) 
HoNOS (n=366) 10·45 (6·44) 8·05 (5·08) 
PROCESS EVALUATION MEASURES 
RKI 2·94 (0·40) 2·97 (0·38) 
MICA 31·37 (6·96) 30·47 (6·96) 
RPS   
      Skills 2·73 (0·66) 2·79 (0·64) 
      Behavioural Intent 1·68 (0·37) 1·66 (0·34) 
      Behaviour 1·74 (0·77) 1·78 (0·78) 
 
Table 1. Baseline sociodemographic and clinical characteristics (n=403) 
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 Regression ICC 
 b, p-value (95%C.I.)  
PATIENT-RATED OUTCOME MEASURES 
QPR Total  0·63, p=·55 (-1·41 to 2·67) 0 
QPR Interpersonal 0·13, p=·75 (-0·93 to 0·67) ·05 
QPR Intrapersonal 0·49, p=·44 (-1·71 to 2·70) 0 
CANSAS-P Met 0·43, p=·43 (-0·63 to 1·49) ·10 
CANSAS-P Unmet -0·31, p=·41 (-1·04 to 0·42) ·03 
HHI 0·65, p=·30 (-0·59 to 1·88) ·03 
MANSA -0·04, p=·73 (-0·27 to 0·19) ·01 
MHCS 2·00, p=·23 (-1·23 to 5·22) ·03 
WEMWBS 0·76, p=·51 (-1·50 to 3·01) ·01 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ 0·71, p=·20 (-0·38 to 1·79) 0 
INSPIRE Support -2·43, p=·41 (-8·22 to 3·36) ·01 
INSPIRE 
Relationship 
-0·39, p=·86 (-4·66 to 3·88) 0 
STAFF-RATED OUTCOME MEASURES 
BPRS -1·85, p=·15 (-4·37 to 0·66) ·12 
CANSAS-S Met 0·07, p=·91 (-1·29 to 1·16) ·13 
CANSAS-S Unmet -0·80, p=·03 (-1·52 to -0·65) ·10 
GAF 5.90, p<·001 (2.61 to 9·18) ·01 
HONOS -1·21, p=·07 (-2·53 to 0·10) ·04 
 
Table 2: ITT comparison between full imputed arms at follow-up, adjusted for 
baseline scores and wave (n= 397; 190 control, 207 intervention) 
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 Control Intervention Overall  Control vs. Low Control vs. High Low vs. High 
  
 
Low 
participation 
High 
participation 
Wald test   
 
 
 n=144 n=67 n=74  b, p-value (95%CI) 
QPR Total 
mean (s.e) 
40·01 (0·59) 40·74 (1·08) 41·30 (0·96) chi2(2)=1·6, 
p=·46 
0·74, p=·55 
(-1·70 to 3·18) 
1·29, p=·26 
(-0·94 to 3·53) 
-0·56, p=·73 
(-3·77 to 2·66) 
QPR Interpersonal 
mean (s.e) 
13·54 (0·20) 12·82 (0·37) 14·39 (0·33) chi2(2)=8·2, 
p=·02 
-0·72, p=·09 
(-1·54 to 0·11) 
0·85, p=·03 
(0·09 to 1·62) 
-1·57, p=·005 
(-2·66 to -
0·48) 
QPR Intrapersonal 
mean (s.e) 
45·36, (0·65) 46·18 (1·18) 46·58 (1·06) chi2(2)=1·2, 
p=·54 
0·82, p=·60 
(-1·87 to 3·50) 
1·21, p=·33 
(-1·24 to 3·67) 
-0·40, p=·83 
(-3·93 to 3·14) 
HoNOS n=168 
10·1, 0·41 
n=59 
7·8, 0·79) 
n=78 
10·1, 0·67) 
chi2(2)=6·71 
p=·03 
-2·32, p=·01 
(-4·08 to ·56) 
-·04, p=·96 
(-1·60 to 1·51) 
-2·36, p=·041 
(-4·62 to -·10) 
GAF n=169 
62·3,  1·07 
n=53 
67·1, 2·17) 
n=82 
69·3, 1·76) 
chi2(2)=14·6 
p<·001 
4.8, p=.051 
(-·01 to 9·58) 
-7·0 p=·001 
(-11·07 to 2·98) 
-2·24, p=·47 
(-8·31 to 3·82) 
 
Table 3: Association between team-level participation and patient-rated recovery, adjusted for baseline (n=285) 
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 Control Intervention Overall  Control vs. 
Low 
Control vs. High Low vs. High 
  
 
Low 
participation 
High 
participation 
Wald test   
 
 
 n 
mean (s.e.) 
n  
mean (s.e.) 
n 
mean (s.e.) 
  
b, p-value (95%CI) 
RKI 129 
2·92 (·03) 
72 
2·89 (·04) 
56 
2·99 (·04) 
chi2(2)=3·0 
p=·23 
-0·03, p=·49 
(-0·12 to 0·06) 
0·06, p=·22 
(-0·04 to 0·16) 
-0·09, p=·09 
(-0·20 to 0·01) 
MICA 131 
30·12 (·55) 
72 
30·78 (·73) 
58 
30·65 (·82) 
chi2(2)=0·6 
p=·75 
0·66, p=·48 
(-1·16 to 2·49) 
0·53, p=·60 
(-1·46 to 2·52) 
0·13, p=·90 
(-2·02 to 2·29) 
RPS        
   Skills 114 
2·87 (·06) 
66 
2·74 (·08) 
50 
2·95 (·09) 
chi2(2)=3·5 
p=·17 
-0·14, p=·16 
(-0·33 to 0·05) 
0·07, p=·33 
(-0·14 to 0·29) 
-0·21, p=·08 
(-0·45 to 0·02) 
   Behavioural intent 114 
1·67 (·03) 
66 
1·60 (·04) 
50 
1·68 (·05) 
chi2(2)=2·2 
p=·33 
-0·07, p=·18 
(-0·18 to 0·03) 
0·01, p=·87 
(-0·11 to 0·13) 
-0·08, p=·21 
(-0·21 to 0·05) 
   Behaviour 114 
1·80 (·07) 
66 
1·54 (·09) 
50 
1·97 (·10) 
chi2(2)=10·9 
p=·004 
-0·26, p=·02 
(-0·48 to -0·05) 
0·16, p=·18 
(-0·08 to 0·40) 
-0·43, p=·001 
(-0·69 to -0·16) 
 
Table 4: Adjusted follow-up scores for staff-rated knowledge, attitudes and behaviour compared between levels of staff 
participation 
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 n (%) using service  Mean (SD) contacts of those using the service 
 Baseline Follow-up  Baseline Follow-up 
Service Control Intervention Control Intervention  Control Intervention Control Intervention 
GP 98 (77) 116 (84) 104 (82) 115 (83)  3·7 (4·0) 3·5 (3·3) 3·3 (5·0) 3·2 (3·1) 
Care coordinator 125 (98) 129 (93) 113 (89) 113 (81)  14·9 (13·0) 10·4 (7·7) 12·1 (12·9) 8·2 (7·1) 
Psychiatrist 77 (61) 92 (66) 82 (65) 76 (55)  2·6 (2·8) 2·9 (3·1) 2·4 (2·1) 2·3 (2·5) 
Other doctor 27 (21) 29 (21) 18 (14) 23 (17)  5·6 (17·0) 2·3 (1·4) 2·1 (1·1) 2·6 (2·2) 
Psychologist 21 (17) 15 (11) 17 (13) 12 (9)  8·6 (10·0) 8·1 (8·8) 10·4 (9·7) 6·0 (7·0) 
Social worker 13 (10) 14 (10) 3 (2) 9 (7)  3·9 (3·8) 8·1 (8·5) 13·3 (9·5) 6·9 (7·4) 
Nurse 16 (13) 13 (9) 21 (17) 20 (14)  19·9 (44·0) 6·6 (6·9) 18·0 (37·8) 14·2 (39·1) 
Occupational therapist 13 (10) 10 (7) 10 (8) 4 (3)  8·5 (10·5) 7·8 (10·2) 5·4 (7·5) 49·5 (87·3) 
Support worker 32 (25) 30 (22) 32 (25) 29 (21)  24·4 (21·6) 29·3 (47·1) 57·6 (64·2) 45·2 (60·1) 
Vocational worker 8 (6) 18 (13) 9 (7) 11 (8)  4·8 (7·5) 5·4 (6·1) 29·3 (58·5) 4·1 (4·8) 
Drug and alcohol advisor 5 (4) 6 (4) 4 (3) 5 (4)  15·0 (18·9) 4·7 (4·3) 18·5 (20·4) 14·0 (12·5) 
Other therapist 11 (9) 8 (6) 5 (4) 7 (5)  27·5 (53·4) 13·0 (11·9) 16·4 (13·1) 9·7 (8·2) 
Psychiatric inpatient 10 (8) 13 (9) 7 (6) 6 (4)  44·0 (50·8) 30·6 (20·8) 67·3 (65·3) 59·7 (75·1) 
Physical inpatient 6 (5) 6 (4) 13 (10) 7 (5)  3·4 (4·0) 3·5 (2·3) 7·7 (16·3) 6·0 (7·1) 
Specialist team 16 (13) 12 (9) 10 (8) 7 (5)  20·9 (34·3) 14·3 (19·3) 13·0 (10·6) 9·6 (9·5) 
Day care 57 (45) 72 (52) 48 (38) 53 (38)  28·9 (31·3) 36·0 (61·4) 35·7 (42·9) 36·3 (45·1) 
 
Table 5. Service use in the six months prior to baseline and the six months prior to one-year follow-up (n=266) 
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Systematic review 
The REFOCUS Intervention is a manualised team-level intervention to improve mental 
health service support for recovery.9 The development of the REFOCUS Intervention was 
informed by primary research and secondary systematic reviews addressing knowledge 
gaps. To undersand how recovery is supported, we completed an inductive, semantic-level 
thematic analysis of 30 international documents describing best pro-recovery practice which 
identified four practice domains.12 The REFOCUS Intervention targets the Supporting 
Recovery and Working Relationships practice domains, and does not target the Promoting 
Citizenship and Organisational Commitment practice domains. To identify recovery 
processes to target through the intervention, we published a systematic review involving 
database searching (AMED, BNI, EMBASE, MEDLINE, PsycINFO, SSP, CINAHL, IBSS, 
ASSIA, BHI, sociological abstracts, SSA, all searched inception-2009), hand-searching of 3 
journals  web-based searching.40 After rating using established quality assessment tools, 
narrative synthesis identified the recovery processes of Connectedness, Hope, Identity, 
Meaning and Empowerment: the CHIME Framework. The framework was subsequently 
validated with current service users41 and cross-culturally.42 To identify the best measure to 
use in WP2 (Strengths assessment) we systematically reviewed measures of strengths.43 To 
identify the optimal primary outcome we systematically reviewed measures of  recovery.19 To 
inform the development of the new INSPIRE measure44 we systematically reviewed 
measures of recovery support.45 To understand staff perspectives, we developed a 
grounded theory of staff experiences of supporting recovery.16 To maximise the feasibility of 
the intervention, we developed a new measure of feasibility based on implementation 
science research.36 Based on this empirical work, and an understanding of social influences 
on recovery,46 we used expert consultation with patients, carers, staff and researchers 
(n=56) to develop the REFOCUS Intervention, the REFOCUS Model9 and the choice of 
secondary outcomes in the REFOCUS Trial.14 
 
Interpretation 
The REFOCUS Trial evaluated REFOCUS, a team-level intervention with an empirically-
supported theory base for patients with psychosis in routine mental health services. The 
most likely explanation for the negative finding in relation to improving recovery is 
inadequate implementation, because higher level staff participation led to more staff-rated 
pro-recovery behaviour and improved interpersonal aspects of patient-rated recovery. The 
trial findings indicate that attention needs additionally to be paid to the Organisational 
Commitment practice domain, to maximise the extent to which supporting recovery is 
organisationally viewed as ‘core business’ rather than an additional task for mental health 
services. 
 
Panel: Research in context 
  
30 
 
Figure 1: Flow Diagram for REFOCUS trial 
 
 
 
 
 
 
 
 
 
  Enrolment 
55 participants lost to 
follow-up 
 34 refused 
 10 lost contact 
 8 too unwell 
 3 died  
57 participants lost 
to follow-up 
 32 refused 
 8 lost contact 
 4 too unwell 
 3 died  
Included in the analysis 
Primary outcome 
n = 14 teams, 153 respondents - 
2 lost due to missing data 
 
Analysis 
Included in the analysis 
Primary outcome 
n = 13 teams, 144 respondents - 
2 lost due to missing data 
 
Followed up  
n = 14, 155 participants 
 
Allocated to intervention  
n = 14 teams, 210 participants    
  
 
 
Allocated to control 
n = 13 teams, 193 participants    
  
 
 
Followed up 
n = 13, 146 participants 
 
Follow-up 
Allocation 
Randomised  
27 teams   
403 participants 
Assessed for eligibility 30 teams 
 1,077 patients 
Excluded 3 teams  
 1 was ineligible  
 2 declined to participate 
Excluded 674 participants 
 409 uncontactable / 
discharged / too unwell / in 
hospital / died 
 265 declined 
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https://kclpure.kcl.ac.uk/portal/en/publications/refocus-trial-protocol-for-a-cluster-randomised-
controlled-trial-of-a-prorecovery-intervention-within-community-based-mental-health-
teams%28a9b855a2-6a38-49c0-b268-94dd9d781e9b%29.html 
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Measure Name and reference Items Range Desirable score 
PATIENT-RATED OUTCOME MEASURES 
QPR Questionnaire about the Process of Recovery18,21    
  QPR Interpersonal 17 0 to 4 High 
  QPR Intrapersonal 5 0 to 4 High 
  QPR Total 15 0 to 4 High 
CANSAS-P Camberwell Assessment of Needs Short Appraisal Schedule – Patient47 22 0 to 22 Low 
HHI Herth Hope Index48 12 12 to 48 High 
MANSA Manchester Short Assessment of Quality of Life49 16 12 to 84 High 
MHCS Mental Health Confidence Scale50 16 16 to 96 High 
WEMWBS Warwick-Edinburgh Mental Well-Being Scale51 14 14 to 70 High 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ Client Satisfaction Questionnaire52 8 8 to 32 High 
INSPIRE INSPIRE44 27 0 to 100 High 
STAFF-RATED OUTCOME MEASURES 
BPRS Brief Psychiatric Rating Scale53 18 0 to 126 Low 
CANSAS-S Camberwell Assessment of Needs Short Appraisal Schedule - Staff47 22 0 to 22 Low 
CSRI Client Service Receipt Inventory54    
GAF Global Assessment of Functioning55 2 0 to 100 High 
HoNOS Health of the Nation Outcome Scale56 12 0 to 48 Low 
PROCESS EVALUATION MEASURES 
RKI Recovery Knowledge Inventory57 20 20 to 100 High 
MICA Mental Illness: Clinicians’ Attitudes58 16 16 to 96 Low 
PS1 Participation Scale 3 Very low to Very high High 
RPS2 Recovery Practice Scale 15 0 to 310 High 
1 Called ‘REFOCUS Implementation Scale (RIS) in protocol. 2 Called Recovery Fidelity Scale (RFS) in protocol. 
 
Appendix Table 1: Description of measures 
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Team name Caseload Screening list Patients 
contacted by 
researchers 
Recruited Allocation 
wave 
Allocation Follow-up 
QPR 
SLaM teams n n n n   n 
Support and Recovery Service (Southbrook Road, Lewisham) 223 147 65 14 SLaM 1 Intervention  12 
Support and Recovery Service (Northover, Lewisham) 223 118 35 15 SLaM 1 Control 11 
Support and Recovery Service (Speedwell, Lewisham) 201 112 51 15 SLaM 1 Intervention 14 
Support and Recovery Service (North East Southwark) 139 100 22 14 SLaM 2 Control 11 
Support and Recovery Service (St Giles - Central Southwark) 192 89 72 17 SLaM 2 Intervention 10 
Support and Recovery Service (St Giles, North Southwark) 167 107 80 15 SLaM 2 Intervention 9 
Support and Recovery Service (St Giles, South Southwark) 185 106 79 15 SLaM 2 Control 13 
Community Forensic Team (Southwark) 67? 82 46 14 SLaM 2 Intervention 7 
Supported living team (Southwark)  69 35 19 16 SLaM 2 Control 10 
Psychosis team East (Croydon) 131 92 58 14 SLaM 3 Control 10 
Psychosis team West (Croydon) 177 115 45 16 SLaM 3 Control 10 
Recovery and Rehabilitation Service (Croydon) 95 75 36 15 SLaM 3 Control 14 
Community Forensic Team (Croydon) 41? 47 27 14 SLaM 3 Intervention 11 
Low intensity team (Croydon) 140 104 30 15 SLaM 3 Intervention 12 
Community Forensic Team (Lewisham) 119 45 75 14 SLaM 4 Control 11 
Support and Recovery Service (South Lambeth) 246 132 35 15 SLaM 4 Intervention 10 
Support and Recovery Service (North Lambeth) 281 149 39 15 SLaM 4 Intervention 8 
Placement Assessment and Monitoring Service (Lambeth) 151 84 40 15 SLaM 4 Control 8 
Gloucester teams        
Stroud Recovery team (1 or 2 cluster) 772 152 18 15 2Gether 1 Intervention 12 
Stroud (and Cotswolds) Assertive Outreach team 53 48 19 15 2Gether 1 Control 13 
Cheltenham and North Cotswolds recovery team 600 168 20 15 2Gether 1 Intervention 12 
Cheltenham and Tewkesbury recovery team 305 65 30 16 2Gether 1 Intervention 11 
Cheltenham Assertive outreach team 68 68 35 14 2Gether 1 Control 11 
Gloucester Recovery team (1 or 2 cluster) 747 85 26 15 2Gether 2 Intervention 11 
Gloucester (and Forest) Assertive Outreach team  103 68 27 15 2Gether 2 Control 11 
Forest of Dean Recovery  250 56 28 15 2Gether 2 Intervention 14 
GRIP early intervention team 211 110 20 15 2Gether 2 Control 11 
Total 5,848 2,559 1,077 403   297 
 
Appendix Table 2: Recruitment and follow-up by team (n=27) 
 
Dates of wave allocation: SLaM 1: 1.7.11; SLaM 2: 1.10.11; SLaM 3: 1.1.12; SLaM 4: 1.4.12; 2Gether 1: 1.11.11; 2Gether 2: 1.4.12 
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  Control  Intervention 
 n (%) n Mean (s.d.)  n Mean (s.d.) 
PATIENT-RATED OUTCOME MEASURES 
QPR Total 275 (69) 134 39.96 (10·2)  141 40·89 (9·9) 
QPR Interpersonal 275 (69) 134 13·46 (2·6)  141 13·81 (2·7) 
QPR Intrapersonal 275 (69) 134 45·30 (11·3)  141 46·044(11·5) 
CANSAS-P Met 284 (72) 137 3·97 (3·1)  147 4·41 (3·2) 
CANSAS-P Unmet 284 (72) 137 3·65 (3·3)  147 3·71 (3·0) 
HHI 264 (66) 127 35·51 (5·7)  137 35·66 (5·1) 
MANSA 240 (60) 113 4·74 (·92)  127 4·80 (0·95) 
MHCS 252 (63) 120 67·26 (13·9)  132 67·20 (15·5) 
WEMWBS 268 (68) 128 47·06 (10·2)  140 48·15 (10·5) 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ 275 (69) 137 25·10 (5·1)  138 26·07 (5.0) 
INSPIRE Relationship 273 (69) 133 77·70 (17·3)  140 79·00 (17·7) 
INSPIRE Support 282 (71) 137 63·59 (21·7)  145 62·61 (24·2) 
STAFF-RATED OUTCOME MEASURES 
BPRS 257 (65) 118 31·27 (10·1)  139 31·16 (10·4) 
CANSAS-S Met 346 (87) 177 5·82 (3·8)  169 5·86 (3·8) 
CANSAS-S Unmet 346 (87) 177 3·12 (3·0)  169 2·54 (2·3) 
GAF 362 (91) 171 64·15 (14·8)  191 67·69 (13·1) 
HONOS 316 (80) 163 11·05 (6·9)  153 8·61 (5·5) 
STAFF-LEVEL PROCESS EVALUATION MEASURES 
RKI 257 129 2·86 (0·4)  128 2.95 (0·4) 
MICA 261 131 30·48 (6·92)  130 30.38 (7·2) 
RPS       
      Skills 230 114 2·91 (0·7)  116 2·84 (0·7) 
      Behavioural Intent 230 114 1·68 (0·3)  116 1·62 (0·4) 
      Behaviour 230 114 1·86 (0·8)  116 1·69 (0·8) 
 
Appendix Table 3. Mean (standard deviation) for non-imputed complete cases 
at follow-up (n=397) 
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n (%) Baseline Follow-up 
PATIENT-RATED OUTCOME MEASURES 
QPR Total  38 (9) 128 (32) 
CANSAS-P 13 (3) 119 (30) 
HHI 41 (10) 139 (35) 
MANSA 128 (32) 163 (40) 
MHCS 68 (17) 151 (37) 
WEMWBS 30 (7) 135 (34) 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ 23 (6) 128 (32) 
INSPIRE Support 7 (2) 121 (30) 
INSPIRE Relationship 26 (6) 130 (32) 
STAFF-RATED OUTCOME MEASURES 
BPRS 54 (13) 146 (36) 
CANSAS-S  16 (7) 57 (14) 
GAF 24 (6) 76 (19) 
HoNOS 37 (9) 87 (22) 
SOCIODEMOGRAPHIC 
Age 27 (7)  
Ethnicity 3 (0·7)  
Accommodation type 4 (1)  
Employment 1 (0·3)  
Relationship status 0 (0)  
Use of mental health services 1 (0·3)  
 
Appendix Table 4. Missing data (n=403) 
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  Regression  
 b, p-value (95%CI) 
PATIENT-RATED OUTCOME MEASURES 
QPR Total 0·61, p=·57 (-1·49 to 2·71) 
QPR Interpersonal -0·09, p=·83 (-0·89 to 0·72) 
QPR Intrapersonal 0·51, p=·66 (-1·76 to 2·78) 
CANSAS-P Met 0·36, p=·53 (-0·77 to 1·48) 
CANSAS-P Unmet -0·21, p=·60 (-0·96 to 0·55) 
HHI 0·60, p=·35 (-0·66 to 1·86) 
MANSA -0·06, p=·61 (-0·29 to 0·17) 
MHCS 1·85, p=·25 (-1·28 to 4·98) 
WEMWBS 0·74, p=·53 (-1·56 to 3·04) 
PATIENT-RATED EXPERIENCE MEASURES 
CSQ 0·80, p=·15 (-0·29 to 1·89) 
INSPIRE Support -2·05, p=·50 (-9·99 to 3·90) 
INSPIRE Relationship -0.29, p=·90 (-4·63 to 4·06) 
STAFF-RATED OUTCOME MEASURES 
BPRS -1·76, p=·17 (-4·29 to 0·77) 
CANSAS-S Met -0·01, p=·99 (-1·22 to 1·22) 
CANSAS-S Unmet -0·68, p=·07 (-1·42 to -0·06) 
GAF 5·32, p =·002 (2·03 to 8·61) 
HONOS -0·89, p=·20 (-2·25 to 0·47) 
 
Appendix Table 5. Comparison between arms, adjusting for baseline levels, 
wave and covariates for imputed data (n=397; 190 control, 207 intervention) 
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  Control  Intervention  Regression  ICC  Cohen’s 
d 
     n n Mean (s.e.)  n Mean (s.e.)  b, p-value (95%C.I.)     
PATIENT-RATED OUTCOME MEASURES        
QPR Total 255 121 40·10 (·64)  134 40·76 (·60)  0·66, p=·46 (-1·09 to 2·41)  0  ·07 
QPR Interpersonal 255 121 13·65 (·22)  134 13·60 (·22)  -0·05, p=·87 (-0·67 to 0·57)  ·01  ·02 
QPR Intrapersonal 255 121 46·51 (·70)  134 46·04 (·66)  0·53, p=·59 (-1·39 to 2·44)  0  ·04 
CANSAS-P Met 271 129 4·13 (·33)  142 4·41 (·31)  0·28, p=·54 (-0·61 to 1·17)  ·05  ·09 
CANSAS-P Unmet 271 129 3·88 (·25)  142 3·69 (·24)  -0·19, p=·59 (-0·88 to 0·50)  ·02  ·06 
HHI 242 113 35·41 (·45)  129 36·04 (·42)  0·63, p=·32 (-0·60 to 1·86)  ·03  ·12 
MANSA 182 84 4·80 (·08)  98 4·88 (·07)  0·07, p=·49 (-0·13 to 0·28)  0  ·09 
MHCS 221 104 67·06 (1·14)  117 67·81 (1·08)  0·75, p=·64 (-2·36 to 3·86)  ·03  ·05 
WEMWBS 269 121 47·24 (·69)  136 48·09 (·65)  0·85, p=·37 (-1·03 to 2·73)  0  ·08 
PATIENT-RATED EXPERIENCE MEASURES        
CSQ 260 127 25·31 (·34)  133 25·99 (·33)  0·68, p=·16 (-0·27 to 1·63)  0  ·13 
INSPIRE Relationship 257 125 78.68 (1·31)  132 78.34 (1·27)  -0·34, p=·85 (-3·96 to 3·28)  0  ·02 
INSPIRE Support 278 135 64·57 (1·74)  143 61·53 (1·70)  -3·04, p=·22 (-7·88 to 1·79)  0  ·13 
STAFF-RATED OUTCOME MEASURES        
BPRS 226 103 32·07 (·80)  123 30·72 (·73)  -1·35, p=·22 (-3·51 to 0·81)  0  ·13 
CANSAS-S Met 256 172 5·73 (·43)  156 5·79 (·42)  0·06, p=·92 (-1·13 to 1·25)  ·12  ·02 
CANSAS-S Unmet 328 172 3·13 (·27)  156 2·26 (·27)  -0·87, p=·03 (-1·63 to -
0·11) 
 ·11  ·32 
GAF 309 169 61·84 (1·06)  140 67·97 (1·16)  6·13, p<·001 (3·03 to 9·23)  ·01  ·41 
HONOS 289 154 10·50 (·46)  135 9·17 (·49)  -1·33, p=·05 (-2·67 to 0·01)  ·03  ·21 
 
Appendix Table 6: ITT comparison for complete cases between arms at follow-up, adjusted for baseline scores and wave 
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Service Cost per 
contact 
(2012/13 £) 
Source 
GP (surgery) 41 Curtis (2013) 
GP (home) 104 Curtis (2013) 
Care coordinator 37 Curtis (2013) 
Psychiatrist 100 Curtis (2013) 
Other doctor 135 Curtis (2013) 
Psychologist 134 Curtis (2013) 
Social worker 113 Curtis (2013) 
Nurse 37 Curtis (2013) 
Occupational therapist 73 Curtis (2013) 
Support worker (base) 21 Curtis (2013) 
Support worker (home) 30 Curtis (2013) 
Vocational worker 30 Curtis (2013) 
Drug and alcohol advisor 54 Curtis (2013) 
Other therapist 58 Curtis (2013) 
Psychiatric inpatient 345 Derived from NHS Reference Costs 
(2007) 
Physical inpatient 577 Derived from NHS Reference Costs 
(2007)  
Specialist team (EI) 185 Curtis (2013) 
Specialist team (ACT) 133 Curtis (2013) 
Specialist team (crisis) 192 Curtis (2013) 
Day care 9·50 per hour Curtis (2013) 
 
Appendix Table 7. Unit costs 
 
References 
Curtis L. Unit costs of health and social care. Canterbury: PSSRU; 2013. 
 
NHS reference costs (2007): 
http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/
Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_082571
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 Baseline  Follow-up 
 Control Intervention  Control Intervention 
Intervention - -  - 120 (92) 
GP 120 (158) 125 (145)  115 (194) 111 (128) 
Care coordinator 542 (484) 357 (291)  401 (470) 247 (264) 
Psychiatrist 157 (250) 191 (285)  156 (205) 127 (220) 
Other doctor 161 (1089) 66 (156)  39 (112) 58 (180) 
Psychologist 190 (684) 117 (505)  186 (661) 69 (349) 
Social worker 45 (189) 93 (405)  36 (266) 50 (279) 
Nurse 93 (613) 23 (104)  110 (610) 76 (568) 
Occupational 
therapist 
63 (303) 41 (241)  31 (181) 104 (1118) 
Support worker 176 (448) 178 (717)  427 (1213) 267 (928) 
Vocational worker 9 (63) 21 (84)  62 (497) 10 (51) 
Drug and alcohol 
advisor 
32 (241) 11 (68)  31 (244) 27 (182) 
Other therapist 138 (981) 43 (235)  37 (230) 28 (158) 
Psychiatric inpatient 1195 (6228) 988 (3740)  1279 (7245) 889 (6479) 
Physical inpatient 93 (619) 87 (481)  454 (3207) 174 (1143) 
Specialist team 435 (2440) 236 (1299)  161 (707) 92 (555) 
Day care 305 (697) 400 (842)  326 (988) 302 (758) 
Total 3754 (7919) 2977 (4305)  3853 (8320) 2752 (8797) 
 
Appendix Table 8. Mean (s.d.) service costs in the six prior to baseline and 
the six months prior to one-year follow-up (2012/13 £s) (n=266) 
 
 
 
